FDA advisory committee

FDA Adcomm

Biotech

After agony, FDA adcomm favors Stealth's ultra-rare disease drug

The FDA advisory committee voted 10-6 supporting Stealth Biotherapeutics’ elamipretide for treating Barth syndrome.

Gabrielle Masson Oct 10, 2024 6:20pm

FDA

FDA scraps adcomm for Applied's rare disease drug

Sep 18, 2024 8:00am

speak chat talk world spread debate globe Earth

With MDMA debate spreading, Lykos CEO tries to dispel concerns

Jun 13, 2024 10:22am

brain alzheimers dementia neuroscience gears thought think

Lilly's donanemab sails through FDA meeting with 2 yes votes

Jun 10, 2024 5:11pm

setback chess beat defeat rook break

Lykos' MDMA treatment rejected by FDA committee

Jun 5, 2024 10:20am

Food and Drug Administration

FDA advisers to weigh first psychedelic therapy in early June

May 7, 2024 11:10am